Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncocyte Corporation logo

SEC Form 4: Gutfreund John Peter was granted 10,000 shares and bought $23,250 worth of shares (25,000 units at $0.93)

ByQuantisnow·Wall Street's wire, on your screen.
OCX· Oncocyte Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.